MiR-326: Promising Biomarker for Cancer.
作者： Yaojie Pan , Jian Wan , Chun-bin Wang
DOI: 10.2147/CMAR.S223875
关键词: Cell growth 、 Oncogene 、 Cancer research 、 Metastasis 、 Biology 、 Cancer 、 microRNA 、 Biomarker 、 Carcinogenesis 、 Signal transduction
摘要: MicroRNAs (miRNAs) are small non-coding and highly conserved RNAs that act in biological processes including cell proliferation, invasion, apoptosis, metabolism, signal transduction, tumorigenesis. The previously identified miRNA-326 (miR-326) has been reported to participate cellular tumor growth, embryonic development, immunomodulation, chemotherapy resistance, oncogenesis. This review presents a detailed overview of what is known about the effects miR-326 on metastasis, drug its involvement signaling pathways.
sci-hub.se 参考文章(99)
Yao Wang, Yong Li, Guanghui Hu, Xuan Huang, Hai Rao, Xiangyang Xiong, Zhijun Luo, Quqin Lu, Shiwen Luo, Nek2A phosphorylates and stabilizes SuFu: A new strategy of Gli2/Hedgehog signaling regulatory mechanism. Cellular Signalling. ,vol. 28, pp. 1304- 1313 ,(2016) , 10.1016/J.CELLSIG.2016.06.010
Wei De, Rui Xia, Yongqian Shu, Wenming Chen, Rong Wang, Tongpeng Xu, Xiaofeng Chen, Liang Han, MiR-326 regulates cell proliferation and migration in lung cancer by targeting phox2a and is regulated by HOTAIR American Journal of Cancer Research. ,vol. 6, pp. 173- 186 ,(2016)
Takashi Kawahara, Ali Kadhim Aljarah, Hasanain Khaleel Shareef, Satoshi Inoue, Hiroki Ide, John D. Patterson, Eiji Kashiwagi, Bin Han, Yi Li, Yichun Zheng, Hiroshi Miyamoto, Silodosin inhibits prostate cancer cell growth via ELK1 inactivation and enhances the cytotoxic activity of gemcitabine The Prostate. ,vol. 76, pp. 744- 756 ,(2016) , 10.1002/PROS.23164
Y Xu, L Qin, T Sun, H Wu, T He, Z Yang, Q Mo, L Liao, J Xu, Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression Oncogene. ,vol. 36, pp. 1157- 1166 ,(2017) , 10.1038/ONC.2016.286
Lei Cao, Jiandong Wang, Prof. Qiugen Wang, MiR-326 is a diagnostic biomarker and regulates cell survival and apoptosis by targeting Bcl-2 in osteosarcoma Biomedicine & Pharmacotherapy. ,vol. 84, pp. 828- 835 ,(2016) , 10.1016/J.BIOPHA.2016.10.008
F Faião-Flores, D K Alves-Fernandes, P C Pennacchi, S Sandri, A L S A Vicente, C Scapulatempo-Neto, V L Vazquez, R M Reis, J Chauhan, C R Goding, K S Smalley, S S Maria-Engler, Targeting the hedgehog transcription factors GLI1 and GLI2 restores sensitivity to vemurafenib-resistant human melanoma cells Oncogene. ,vol. 36, pp. 1849- 1861 ,(2017) , 10.1038/ONC.2016.348
Zahid Nawaz, Vikas Patil, Yashna Paul, Alangar S. Hegde, Arimappamagan Arivazhagan, Vani Santosh, Kumaravel Somasundaram, PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA. Molecular Cancer. ,vol. 15, pp. 74- 74 ,(2016) , 10.1186/S12943-016-0557-8
Maximiliano Cagel, Estefanía Grotz, Ezequiel Bernabeu, Marcela A. Moretton, Diego A. Chiappetta, Doxorubicin: nanotechnological overviews from bench to bedside. Drug Discovery Today. ,vol. 22, pp. 270- 281 ,(2017) , 10.1016/J.DRUDIS.2016.11.005
Wei Rj, Feng Jb, Yu Yl, Liu Ps, Li R, Dai J, A study of CCND1 with epithelial ovarian cancer cell proliferation and apoptosis. European Review for Medical and Pharmacological Sciences. ,vol. 20, pp. 4230- 4235 ,(2016)
Zhixiang Zhao, Mohammad Aminur Rahman, Zhuo G Chen, Dong M Shin, None, Multiple biological functions of Twist1 in various cancers Oncotarget. ,vol. 8, pp. 20380- 20393 ,(2017) , 10.18632/ONCOTARGET.14608